Ischemia, Peripheral Arterial Disease and Thrombolysis

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Ischemia

Peripheral Arterial Disease

Thrombolysis

Acute Limb Ischemia After Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Journal of the American Heart Association

APRIL 23, 2025

A total of 629 656 patients underwent PCI for stable coronary artery disease. Peripheral artery disease was the strongest predictor of postPCI ALI (odds ratio, 53.03 [95% CI, 43.7664.28],P<0.001). received thrombolysis. Peripheral artery disease is the strongest predictor of postPCI ALI.

Coronary Artery Disease

Coronary Artery Disease Ischemia Peripheral Arterial Disease Thrombolysis

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Circulation

OCTOBER 18, 2023

BACKGROUND:Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) trial.

Peripheral Arterial Disease

Peripheral Arterial Disease Myocardial Infarction Thrombolysis Ischemia

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Cardiovascular Update

Acute Limb Ischemia After Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Webinars

Stay Connected